CAM
IHE icon

Congress Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Congress Asset Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$55.8K Buy
+55,779
New +$5.72M ﹤0.01% 396

Other funds holding IHE

CCA
Cadent Capital Advisors Tulsa, Oklahoma $466M AUM 30.56% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PA
Prism Advisors Studio City, California $399M AUM 13.01% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Congress Asset Management's IHE Position: Q3 2026 in Review

Congress Asset Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 55,779 shares worth $55.8K. The stake represents ﹤0.01% of the portfolio and ranks #396 among its holdings.

7 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Congress Asset Management held 55,779 shares of iShares US Pharmaceuticals ETF worth $55.8K as of Q3 2026.
  • iShares US Pharmaceuticals ETF was a new Congress Asset Management position in Q3 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Congress Asset Management's portfolio in Q3 2026, its #396 holding.
  • 7 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.